Chargement en cours...
Sunitinib rechallenge with dose escalation in progressive metastatic renal cell carcinoma: A case report and literature review
RATIONALE: We aimed to present a case of sunitinib rechallenge with dosage escalation after disease progression, hopefully, providing an optional approach to the personalized medication management of progressive metastatic renal cell carcinoma (mRCC). PATIENT CONCERNS: The patient was admitted to ho...
Enregistré dans:
| Publié dans: | Medicine (Baltimore) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081141/ https://ncbi.nlm.nih.gov/pubmed/30075524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011565 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|